FDA approves donanemab; Banner Alzheimer’s trial participants interviewed in N.Y. Times
FDA approves donanemab; Banner Alzheimer’s trial participants interviewed in N.Y. Times The FDA on Tuesday approved a new drug for Alzheimer’s disease, and clinical trials at both Banner Alzheimer’s Institute locations and Banner Sun Health Research Institute provided data...
Read moreBanner Health hires renowned leader for new biomarker research program
Nicholas Ashton’s program aims to discover, galvanize use of new blood tests in fight against Alzheimer’s and related diseases PHOENIX (May 15, 2024) – Emerging blood tests have begun to revolutionize the fight against Alzheimer’s disease, the most common...
Read moreThe Arizona Alzheimer’s Consortium honors philanthropist Jerre Stead for extraordinary contributions to the scientific and clinical fight against Alzheimer’s disease
PHOENIX, Ariz. – On Saturday, April 27 the Arizona Alzheimer’s Consortium will hold its always-anticipated public conference, a free event for the community where more than 300 patients, caregivers, family members, and interested persons gather with Alzheimer’s researchers, caregiving...
Read more